Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
Post Doctoral Researcher in Human-Centered AI for Software Engineering, Department of Electrical ...
The Section for Software Engineering and Computing Systems, at the Department of Electrical and Computer Engineering (ECE), invites applicants for a two-year postdoctoral position within the area of
-
. To achieve such an ambitious goal, the candidates are expected to bring us with new ideas, new technological advance and highly skilled in experimental methods. More details about our laboratory can be found
-
and clinical translation. Supported by the Carl Zeiss Foundation , an ERC Starting Grant , and the DFG Emmy Noether Program, our lab provides a highly collaborative and interdisciplinary environment
-
the end of 10th September 2025. (this is the only method that applications can be made). The start date is by mutual agreement. As part of your application, you should upload the following documents
-
diffraction and related scattering methods, Raman spectroscopy, electron microscopy (SEM and TEM). Carry out electrochemical characterization of the materials in half cells as well as in full sodium ion battery
-
researchers working with a wide range of specialisms and methods, giving you ample opportunity to exchange knowledge and experience with the various scientific fields within medicine and health. It is the
-
The Ghezzi Lab at University of Massachusetts Lowell is looking for a full-time, fully benefitted Postdoctoral Research Associate to participate in a NIH-funded research program which aims
-
-funded financial support for salary or stipends (e.g., National Research Foundation Mid-Career Researcher Program, Jang Young-Shil Fellow, or similar programs), duplicate funding is not allowed. Applicants
-
for artificial intelligence in life sciences, we benefit from high-throughput computing infrastructure to support advanced data analysis and integration. Profile We are looking for a motivated postdoctoral
-
, computational drug repurposing, and de novo design of novel protein-based therapeutics. Our work also includes developing gene editing strategies to correct or inactivate mutations associated with severe